Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NMN
|
|||
| Former ID |
DIB005625
|
|||
| Drug Name |
ALORACETAM
|
|||
| Synonyms |
Aloracetam; N-[2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide; 1-(2-Acetamidoethyl)-2,5-dimethylpyrrole-3-carboxaldehyde
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Discontinued in Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H16N2O2
|
|||
| Canonical SMILES |
CC1=CC(=C(N1CCNC(=O)C)C)C=O
|
|||
| InChI |
1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15)
|
|||
| InChIKey |
ZUQSGZULKDDMEW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 119610-26-3
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001404) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.